06.16.21
Kindra, a wellness brand for menopause formed through a partnership with P&G Ventures, has closed a $4.5 million seed funding round.
The round was led by the Female Founders Fund. Primetime Partners, Anne and Susan Wojcicki, Katie Couric Media, The Community Fund, and H Ventures are also investors in this round.
Kindra formulates estrogen-free and plant-powered menopause essentials including vaginal lotion and naturally-derived supplements that address some of most common effects of menopause including sleeplessness, hot flashes, brain fog, vaginal dryness, and more.
The new capital will be used to drive the continued growth and expansion of the brand, said officials.
“The investor community is now drawn to the menopause category because they recognize the needs of this important demographic that is demanding attention and innovative solutions,” said Catherine Balsam-Schwaber, CEO, Kindra. “Kindra’s raise garnered an enthusiastic response from some of the most highly regarded funders because they believe in our science-backed premium products as well as our mission to speak out loud about menopause to help create a positive cultural shift. With our funders’ support, we are now poised to reach and serve the 6,000 women who enter menopause each day with even greater impact.”
Anu Duggal, founding partner of Female Founders Fund, says the women’s health space is one of the most promising areas of investment with women controlling 80% of all healthcare buying and usage decisions in a $3.5 trillion healthcare industry.
“Primetime Partners is thrilled to be on this journey with Kindra and invest in the fastest growing segment of our population,” said Abby Levy, managing partner and co-founder, Primetime Partners. “By 2030, there will be more women between the ages of 40 and 64 than women under 18 - this demographic shift is fueling innovation focused on improving our quality of life as we age. With Catherine’s leadership, Kindra has the edge we are constantly looking for in emergent brands and new platforms to help deliver high-quality, clinically proven products that are directly available to consumers and actually relieve women and improve their overall experiences.”
The round was led by the Female Founders Fund. Primetime Partners, Anne and Susan Wojcicki, Katie Couric Media, The Community Fund, and H Ventures are also investors in this round.
Kindra formulates estrogen-free and plant-powered menopause essentials including vaginal lotion and naturally-derived supplements that address some of most common effects of menopause including sleeplessness, hot flashes, brain fog, vaginal dryness, and more.
The new capital will be used to drive the continued growth and expansion of the brand, said officials.
“The investor community is now drawn to the menopause category because they recognize the needs of this important demographic that is demanding attention and innovative solutions,” said Catherine Balsam-Schwaber, CEO, Kindra. “Kindra’s raise garnered an enthusiastic response from some of the most highly regarded funders because they believe in our science-backed premium products as well as our mission to speak out loud about menopause to help create a positive cultural shift. With our funders’ support, we are now poised to reach and serve the 6,000 women who enter menopause each day with even greater impact.”
Anu Duggal, founding partner of Female Founders Fund, says the women’s health space is one of the most promising areas of investment with women controlling 80% of all healthcare buying and usage decisions in a $3.5 trillion healthcare industry.
“Primetime Partners is thrilled to be on this journey with Kindra and invest in the fastest growing segment of our population,” said Abby Levy, managing partner and co-founder, Primetime Partners. “By 2030, there will be more women between the ages of 40 and 64 than women under 18 - this demographic shift is fueling innovation focused on improving our quality of life as we age. With Catherine’s leadership, Kindra has the edge we are constantly looking for in emergent brands and new platforms to help deliver high-quality, clinically proven products that are directly available to consumers and actually relieve women and improve their overall experiences.”